Patel Sanj K sold KNSA

November 3, 2026 · Form 4 insider transaction

Patel Sanj K sold 68,664 shares of Kiniksa Pharmaceuticals International, plc at $92.70 per share, a transaction worth $6.37M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.

Direction
Disposed (sell-side)
Shares
68,664
Price
$92.70
Total value
$6.37M
RoleOfficer, Director
SecurityClass A Ordinary Share
Transaction codeS: Open-market sale
Transaction dateNovember 3, 2026
Filing dateNovember 3, 2026
Shares owned after930,329
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on July 30, 2026.; This transaction was executed in multiple trades through a broker-dealer at prices ranging between $92.085 and $93.08. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.

View the original Form 4 on SEC EDGAR